APO Research
Talk to an analyst

APO RESEARCH · REPORT

Second Generation Sulfonylureas

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Second Generation Sulfonylureas Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025197 pages

Choose your research edition.

Industry ResearchSecond Generation Sulfonylureas Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Second Generation Sulfonylureas Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Second Generation Sulfonylureas Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Second Generation Sulfonylureas Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Second Generation Sulfonylureas Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Second Generation Sulfonylureas market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Second Generation Sulfonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Second Generation Sulfonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Second Generation Sulfonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Second Generation Sulfonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Second Generation Sulfonylureas include United Laboratories, Yiling Pharmaceutical, Takeda, Sanofi, Novo Nordisk, Merck, Eli Lilly, Jiangsu Hengrui Pharmaceuticals and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Second Generation Sulfonylureas market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Second Generation Sulfonylureas and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Second Generation Sulfonylureas sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Second Generation Sulfonylureas market size, projected growth trends, production technologies, key applications, and end-use industries.

Second Generation Sulfonylureas Segment by Company

United Laboratories

Yiling Pharmaceutical

Takeda

Sanofi

Novo Nordisk

Merck

Eli Lilly

Jiangsu Hengrui Pharmaceuticals

Pfizer

Beijing Double-Crane Pharmaceutical

Huadong Medicine

Beijing Beilu Pharmaceutical

AstraZeneca

Boehringer Ingelheim

Second Generation Sulfonylureas Segment by Type

Glyburide

Glipizide

Gliclazide

Others

Second Generation Sulfonylureas Segment by Application

Clinic

Hospital

Pharmacy

Others

Second Generation Sulfonylureas Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Second Generation Sulfonylureas market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Second Generation Sulfonylureas and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Second Generation Sulfonylureas.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Second Generation Sulfonylureas market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Second Generation Sulfonylureas manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Second Generation Sulfonylureas in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Second Generation Sulfonylureas in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Second Generation Sulfonylureas Industry Trends Table 2. Second Generation Sulfonylureas Industry Drivers Table 3. Second Generation Sulfonylureas Industry Opportunities and Challenges Table 4. Second Generation Sulfonylureas Industry Restraints Table 5. Global Second Generation Sulfonylureas Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Second Generation Sulfonylureas Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Second Generation Sulfonylureas Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Second Generation Sulfonylureas Sales Market Share by Manufacturers Table 9. Global Second Generation Sulfonylureas Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Second Generation Sulfonylureas Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Second Generation Sulfonylureas Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Second Generation Sulfonylureas Manufacturers, Product Type & Application Table 13. Global Second Generation Sulfonylureas Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Second Generation Sulfonylureas by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Glyburide Table 17. Major Manufacturers of Glipizide Table 18. Major Manufacturers of Gliclazide Table 19. Major Manufacturers of Others Table 20. Global Second Generation Sulfonylureas Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Second Generation Sulfonylureas Sales by Type (2021-2026) & (k units) Table 22. Global Second Generation Sulfonylureas Sales by Type (2027-2032) & (k units) Table 23. Global Second Generation Sulfonylureas Sales Market Share by Type (2021-2026) Table 24. Global Second Generation Sulfonylureas Sales Market Share by Type (2027-2032) Table 25. Global Second Generation Sulfonylureas Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Second Generation Sulfonylureas Revenue by Type (2021-2026) & (k units) Table 27. Global Second Generation Sulfonylureas Revenue by Type (2027-2032) & (k units) Table 28. Global Second Generation Sulfonylureas Revenue Market Share by Type (2021-2026) Table 29. Global Second Generation Sulfonylureas Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Pharmacy Table 33. Major Manufacturers of Others Table 34. Global Second Generation Sulfonylureas Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Second Generation Sulfonylureas Sales by Application (2021-2026) & (k units) Table 36. Global Second Generation Sulfonylureas Sales by Application (2027-2032) & (k units) Table 37. Global Second Generation Sulfonylureas Sales Market Share by Application (2021-2026) Table 38. Global Second Generation Sulfonylureas Sales Market Share by Application (2027-2032) Table 39. Global Second Generation Sulfonylureas Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Second Generation Sulfonylureas Revenue by Application (2021-2026) & (k units) Table 41. Global Second Generation Sulfonylureas Revenue by Application (2027-2032) & (k units) Table 42. Global Second Generation Sulfonylureas Revenue Market Share by Application (2021-2026) Table 43. Global Second Generation Sulfonylureas Revenue Market Share by Application (2027-2032) Table 44. Global Second Generation Sulfonylureas Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Second Generation Sulfonylureas Sales by Region (2021-2026) & (k units) Table 46. Global Second Generation Sulfonylureas Sales Market Share by Region (2021-2026) Table 47. Global Second Generation Sulfonylureas Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Second Generation Sulfonylureas Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Second Generation Sulfonylureas Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Second Generation Sulfonylureas Sales by Country (2021-2026) & (k units) Table 51. North America Second Generation Sulfonylureas Sales by Country (2027-2032) & (k units) Table 52. Europe Second Generation Sulfonylureas Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Second Generation Sulfonylureas Sales by Country (2021-2026) & (k units) Table 54. Europe Second Generation Sulfonylureas Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Second Generation Sulfonylureas Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Second Generation Sulfonylureas Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Second Generation Sulfonylureas Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Second Generation Sulfonylureas Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Second Generation Sulfonylureas Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Second Generation Sulfonylureas Sales by Country (2027-2032) & (k units) Table 61. Global Second Generation Sulfonylureas Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Second Generation Sulfonylureas Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Second Generation Sulfonylureas Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Second Generation Sulfonylureas Revenue Market Share by Region (2021-2026) Table 65. Global Second Generation Sulfonylureas Revenue Market Share by Region (2027-2032) Table 66. United Laboratories Company Information Table 67. United Laboratories Business Overview Table 68. United Laboratories Second Generation Sulfonylureas Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. United Laboratories Second Generation Sulfonylureas Product Portfolio Table 70. United Laboratories Recent Development Table 71. Yiling Pharmaceutical Company Information Table 72. Yiling Pharmaceutical Business Overview Table 73. Yiling Pharmaceutical Second Generation Sulfonylureas Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Yiling Pharmaceutical Second Generation Sulfonylureas Product Portfolio Table 75. Yiling Pharmaceutical Recent Development Table 76. Takeda Company Information Table 77. Takeda Business Overview Table 78. Takeda Second Generation Sulfonylureas Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Takeda Second Generation Sulfonylureas Product Portfolio Table 80. Takeda Recent Development Table 81. Sanofi Company Information Table 82. Sanofi Business Overview Table 83. Sanofi Second Generation Sulfonylureas Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Sanofi Second Generation Sulfonylureas Product Portfolio Table 85. Sanofi Recent Development Table 86. Novo Nordisk Company Information Table 87. Novo Nordisk Business Overview Table 88. Novo Nordisk Second Generation Sulfonylureas Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Novo Nordisk Second Generation Sulfonylureas Product Portfolio Table 90. Novo Nordisk Recent Development Table 91. Merck Company Information Table 92. Merck Business Overview Table 93. Merck Second Generation Sulfonylureas Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Merck Second Generation Sulfonylureas Product Portfolio Table 95. Merck Recent Development Table 96. Eli Lilly Company Information Table 97. Eli Lilly Business Overview Table 98. Eli Lilly Second Generation Sulfonylureas Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Eli Lilly Second Generation Sulfonylureas Product Portfolio Table 100. Eli Lilly Recent Development Table 101. Jiangsu Hengrui Pharmaceuticals Company Information Table 102. Jiangsu Hengrui Pharmaceuticals Business Overview Table 103. Jiangsu Hengrui Pharmaceuticals Second Generation Sulfonylureas Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Jiangsu Hengrui Pharmaceuticals Second Generation Sulfonylureas Product Portfolio Table 105. Jiangsu Hengrui Pharmaceuticals Recent Development Table 106. Pfizer Company Information Table 107. Pfizer Business Overview Table 108. Pfizer Second Generation Sulfonylureas Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Pfizer Second Generation Sulfonylureas Product Portfolio Table 110. Pfizer Recent Development Table 111. Beijing Double-Crane Pharmaceutical Company Information Table 112. Beijing Double-Crane Pharmaceutical Business Overview Table 113. Beijing Double-Crane Pharmaceutical Second Generation Sulfonylureas Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Beijing Double-Crane Pharmaceutical Second Generation Sulfonylureas Product Portfolio Table 115. Beijing Double-Crane Pharmaceutical Recent Development Table 116. Huadong Medicine Company Information Table 117. Huadong Medicine Business Overview Table 118. Huadong Medicine Second Generation Sulfonylureas Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Huadong Medicine Second Generation Sulfonylureas Product Portfolio Table 120. Huadong Medicine Recent Development Table 121. Beijing Beilu Pharmaceutical Company Information Table 122. Beijing Beilu Pharmaceutical Business Overview Table 123. Beijing Beilu Pharmaceutical Second Generation Sulfonylureas Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Beijing Beilu Pharmaceutical Second Generation Sulfonylureas Product Portfolio Table 125. Beijing Beilu Pharmaceutical Recent Development Table 126. AstraZeneca Company Information Table 127. AstraZeneca Business Overview Table 128. AstraZeneca Second Generation Sulfonylureas Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. AstraZeneca Second Generation Sulfonylureas Product Portfolio Table 130. AstraZeneca Recent Development Table 131. Boehringer Ingelheim Company Information Table 132. Boehringer Ingelheim Business Overview Table 133. Boehringer Ingelheim Second Generation Sulfonylureas Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Boehringer Ingelheim Second Generation Sulfonylureas Product Portfolio Table 135. Boehringer Ingelheim Recent Development Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Second Generation Sulfonylureas Distributors List Table 139. Second Generation Sulfonylureas Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Second Generation Sulfonylureas Product Image Figure 2. Global Second Generation Sulfonylureas Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Second Generation Sulfonylureas Market Size (2021-2032) & (US$ Million) Figure 4. Global Second Generation Sulfonylureas Sales (2021-2032) & (k units) Figure 5. Global Second Generation Sulfonylureas Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Second Generation Sulfonylureas Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Glyburide Image Figure 9. Glipizide Image Figure 10. Gliclazide Image Figure 11. Others Image Figure 12. Global Second Generation Sulfonylureas Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Second Generation Sulfonylureas Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Second Generation Sulfonylureas Sales Market Share by Type (2021-2032) Figure 15. Global Second Generation Sulfonylureas Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Second Generation Sulfonylureas Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Second Generation Sulfonylureas Revenue Market Share by Type (2021-2032) Figure 18. Clinic Image Figure 19. Hospital Image Figure 20. Pharmacy Image Figure 21. Others Image Figure 22. Global Second Generation Sulfonylureas Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Second Generation Sulfonylureas Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Second Generation Sulfonylureas Sales Market Share by Application (2021-2032) Figure 25. Global Second Generation Sulfonylureas Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Second Generation Sulfonylureas Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Second Generation Sulfonylureas Revenue Market Share by Application (2021-2032) Figure 28. North America Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Second Generation Sulfonylureas Sales Market Share by Country (2021-2032) Figure 30. U.S. Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Second Generation Sulfonylureas Sales Market Share by Country (2021-2032) Figure 35. Germany Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Second Generation Sulfonylureas Sales Market Share by Country (2021-2032) Figure 42. China Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Second Generation Sulfonylureas Sales Market Share by Country (2021-2032) Figure 50. Brazil Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Second Generation Sulfonylureas Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Second Generation Sulfonylureas Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Second Generation Sulfonylureas Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Second Generation Sulfonylureas Revenue (2021-2032) & (US$ Million) Figure 61. North America Second Generation Sulfonylureas Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Second Generation Sulfonylureas Revenue (2021-2032) & (US$ Million) Figure 63. Europe Second Generation Sulfonylureas Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Second Generation Sulfonylureas Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Second Generation Sulfonylureas Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Second Generation Sulfonylureas Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Second Generation Sulfonylureas Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Second Generation Sulfonylureas Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Second Generation Sulfonylureas Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Glyburide
  • Glipizide
  • Gliclazide
  • Others
Applications
  • Clinic
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • United Laboratories
  • Yiling Pharmaceutical
  • Takeda
  • Sanofi
  • Novo Nordisk
  • Merck
  • Eli Lilly
  • Jiangsu Hengrui Pharmaceuticals
  • Pfizer
  • Beijing Double-Crane Pharmaceutical
  • Huadong Medicine
  • Beijing Beilu Pharmaceutical
  • AstraZeneca
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Second Generation Sulfonylureas Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Second Generation Sulfonylureas Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Second Generation Sulfonylureas Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Second Generation Sulfonylureas Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Second Generation Sulfonylureas Market Dynamics
  1. 2.1 Second Generation Sulfonylureas Industry Trends
  2. 2.2 Second Generation Sulfonylureas Industry Drivers
  3. 2.3 Second Generation Sulfonylureas Industry Opportunities and Challenges
  4. 2.4 Second Generation Sulfonylureas Industry Restraints
3 Second Generation Sulfonylureas Market by Manufacturers
  1. 3.1 Global Second Generation Sulfonylureas Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Second Generation Sulfonylureas Sales by Manufacturers (2021-2026)
  3. 3.3 Global Second Generation Sulfonylureas Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Second Generation Sulfonylureas Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Second Generation Sulfonylureas Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Second Generation Sulfonylureas Manufacturers, Product Type & Application
  7. 3.7 Global Second Generation Sulfonylureas Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Second Generation Sulfonylureas Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Second Generation Sulfonylureas Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Second Generation Sulfonylureas Tier 1, Tier 2, and Tier 3
4 Second Generation Sulfonylureas Market by Type
  1. 4.1 Second Generation Sulfonylureas Type Introduction
  2. 4.1.1 Glyburide
  3. 4.1.2 Glipizide
  4. 4.1.3 Gliclazide
  5. 4.1.4 Others
  6. 4.2 Global Second Generation Sulfonylureas Sales by Type
  7. 4.2.1 Global Second Generation Sulfonylureas Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Second Generation Sulfonylureas Sales by Type (2021-2032)
  9. 4.2.3 Global Second Generation Sulfonylureas Sales Market Share by Type (2021-2032)
  10. 4.3 Global Second Generation Sulfonylureas Revenue by Type
  11. 4.3.1 Global Second Generation Sulfonylureas Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Second Generation Sulfonylureas Revenue by Type (2021-2032)
  13. 4.3.3 Global Second Generation Sulfonylureas Revenue Market Share by Type (2021-2032)
5 Second Generation Sulfonylureas Market by Application
  1. 5.1 Second Generation Sulfonylureas Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Second Generation Sulfonylureas Sales by Application
  7. 5.2.1 Global Second Generation Sulfonylureas Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Second Generation Sulfonylureas Sales by Application (2021-2032)
  9. 5.2.3 Global Second Generation Sulfonylureas Sales Market Share by Application (2021-2032)
  10. 5.3 Global Second Generation Sulfonylureas Revenue by Application
  11. 5.3.1 Global Second Generation Sulfonylureas Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Second Generation Sulfonylureas Revenue by Application (2021-2032)
  13. 5.3.3 Global Second Generation Sulfonylureas Revenue Market Share by Application (2021-2032)
6 Global Second Generation Sulfonylureas Sales by Region
  1. 6.1 Global Second Generation Sulfonylureas Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Second Generation Sulfonylureas Sales by Region (2021-2032)
  3. 6.2.1 Global Second Generation Sulfonylureas Sales by Region (2021-2026)
  4. 6.2.2 Global Second Generation Sulfonylureas Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Second Generation Sulfonylureas Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Second Generation Sulfonylureas Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Second Generation Sulfonylureas Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Second Generation Sulfonylureas Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Second Generation Sulfonylureas Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Second Generation Sulfonylureas Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Second Generation Sulfonylureas Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Second Generation Sulfonylureas Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Second Generation Sulfonylureas Revenue by Region
  1. 7.1 Global Second Generation Sulfonylureas Revenue by Region
  2. 7.1.1 Global Second Generation Sulfonylureas Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Second Generation Sulfonylureas Revenue by Region (2021-2026)
  4. 7.1.3 Global Second Generation Sulfonylureas Revenue by Region (2027-2032)
  5. 7.1.4 Global Second Generation Sulfonylureas Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Second Generation Sulfonylureas Revenue (2021-2032)
  8. 7.2.2 North America Second Generation Sulfonylureas Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Second Generation Sulfonylureas Revenue (2021-2032)
  11. 7.3.2 Europe Second Generation Sulfonylureas Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Second Generation Sulfonylureas Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Second Generation Sulfonylureas Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Second Generation Sulfonylureas Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Second Generation Sulfonylureas Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 United Laboratories
  2. 8.1.1 United Laboratories Company Information
  3. 8.1.2 United Laboratories Business Overview
  4. 8.1.3 United Laboratories Second Generation Sulfonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 United Laboratories Second Generation Sulfonylureas Product Portfolio
  6. 8.1.5 United Laboratories Recent Developments
  7. 8.2 Yiling Pharmaceutical
  8. 8.2.1 Yiling Pharmaceutical Company Information
  9. 8.2.2 Yiling Pharmaceutical Business Overview
  10. 8.2.3 Yiling Pharmaceutical Second Generation Sulfonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yiling Pharmaceutical Second Generation Sulfonylureas Product Portfolio
  12. 8.2.5 Yiling Pharmaceutical Recent Developments
  13. 8.3 Takeda
  14. 8.3.1 Takeda Company Information
  15. 8.3.2 Takeda Business Overview
  16. 8.3.3 Takeda Second Generation Sulfonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Takeda Second Generation Sulfonylureas Product Portfolio
  18. 8.3.5 Takeda Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi Second Generation Sulfonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Second Generation Sulfonylureas Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
  25. 8.5 Novo Nordisk
  26. 8.5.1 Novo Nordisk Company Information
  27. 8.5.2 Novo Nordisk Business Overview
  28. 8.5.3 Novo Nordisk Second Generation Sulfonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novo Nordisk Second Generation Sulfonylureas Product Portfolio
  30. 8.5.5 Novo Nordisk Recent Developments
  31. 8.6 Merck
  32. 8.6.1 Merck Company Information
  33. 8.6.2 Merck Business Overview
  34. 8.6.3 Merck Second Generation Sulfonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck Second Generation Sulfonylureas Product Portfolio
  36. 8.6.5 Merck Recent Developments
  37. 8.7 Eli Lilly
  38. 8.7.1 Eli Lilly Company Information
  39. 8.7.2 Eli Lilly Business Overview
  40. 8.7.3 Eli Lilly Second Generation Sulfonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Eli Lilly Second Generation Sulfonylureas Product Portfolio
  42. 8.7.5 Eli Lilly Recent Developments
  43. 8.8 Jiangsu Hengrui Pharmaceuticals
  44. 8.8.1 Jiangsu Hengrui Pharmaceuticals Company Information
  45. 8.8.2 Jiangsu Hengrui Pharmaceuticals Business Overview
  46. 8.8.3 Jiangsu Hengrui Pharmaceuticals Second Generation Sulfonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jiangsu Hengrui Pharmaceuticals Second Generation Sulfonylureas Product Portfolio
  48. 8.8.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer Second Generation Sulfonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Second Generation Sulfonylureas Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 Beijing Double-Crane Pharmaceutical
  56. 8.10.1 Beijing Double-Crane Pharmaceutical Company Information
  57. 8.10.2 Beijing Double-Crane Pharmaceutical Business Overview
  58. 8.10.3 Beijing Double-Crane Pharmaceutical Second Generation Sulfonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Beijing Double-Crane Pharmaceutical Second Generation Sulfonylureas Product Portfolio
  60. 8.10.5 Beijing Double-Crane Pharmaceutical Recent Developments
  61. 8.11 Huadong Medicine
  62. 8.11.1 Huadong Medicine Company Information
  63. 8.11.2 Huadong Medicine Business Overview
  64. 8.11.3 Huadong Medicine Second Generation Sulfonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Huadong Medicine Second Generation Sulfonylureas Product Portfolio
  66. 8.11.5 Huadong Medicine Recent Developments
  67. 8.12 Beijing Beilu Pharmaceutical
  68. 8.12.1 Beijing Beilu Pharmaceutical Company Information
  69. 8.12.2 Beijing Beilu Pharmaceutical Business Overview
  70. 8.12.3 Beijing Beilu Pharmaceutical Second Generation Sulfonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Beijing Beilu Pharmaceutical Second Generation Sulfonylureas Product Portfolio
  72. 8.12.5 Beijing Beilu Pharmaceutical Recent Developments
  73. 8.13 AstraZeneca
  74. 8.13.1 AstraZeneca Company Information
  75. 8.13.2 AstraZeneca Business Overview
  76. 8.13.3 AstraZeneca Second Generation Sulfonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AstraZeneca Second Generation Sulfonylureas Product Portfolio
  78. 8.13.5 AstraZeneca Recent Developments
  79. 8.14 Boehringer Ingelheim
  80. 8.14.1 Boehringer Ingelheim Company Information
  81. 8.14.2 Boehringer Ingelheim Business Overview
  82. 8.14.3 Boehringer Ingelheim Second Generation Sulfonylureas Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Boehringer Ingelheim Second Generation Sulfonylureas Product Portfolio
  84. 8.14.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Second Generation Sulfonylureas Value Chain Analysis
  2. 9.1.1 Second Generation Sulfonylureas Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Second Generation Sulfonylureas Production Mode & Process
  6. 9.2 Second Generation Sulfonylureas Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Second Generation Sulfonylureas Distributors
  9. 9.2.3 Second Generation Sulfonylureas Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst